Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

Hypofractionated stereotactic radiotherapy in medium-sized to large arteriovenous malformations.

Lindvall P, Grayson D, Bergström P, Bergenheim AT.

J Clin Neurosci. 2015 Jun;22(6):955-8. doi: 10.1016/j.jocn.2014.12.015. Epub 2015 Mar 28.

PMID:
25827867
2.

The effect of image quality and forensic expertise in facial image comparisons.

Norell K, Läthén KB, Bergström P, Rice A, Natu V, O'Toole A.

J Forensic Sci. 2015 Mar;60(2):331-40. doi: 10.1111/1556-4029.12660. Epub 2014 Dec 23.

PMID:
25537273
3.

Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.

von Otter M, Bergström P, Quattrone A, De Marco EV, Annesi G, Söderkvist P, Wettinger SB, Drozdzik M, Bialecka M, Nissbrandt H, Klein C, Nilsson M, Hammarsten O, Nilsson S, Zetterberg H.

BMC Med Genet. 2014 Dec 12;15:131. doi: 10.1186/s12881-014-0131-4.

4.

Flow cytometry-based functional selection of RNA interference triggers for efficient epi-allelic analysis of therapeutic targets.

Micklem DR, Blø M, Bergström P, Hodneland E, Tiron C, Høiby T, Gjerdrum C, Hammarsten O, Lorens JB.

BMC Biotechnol. 2014 Jun 21;14:57. doi: 10.1186/1472-6750-14-57.

5.

Repeated Nrf2 stimulation using sulforaphane protects fibroblasts from ionizing radiation.

Mathew ST, Bergström P, Hammarsten O.

Toxicol Appl Pharmacol. 2014 May 1;276(3):188-94. doi: 10.1016/j.taap.2014.02.013. Epub 2014 Mar 3.

PMID:
24603300
6.

Dual-wavelength digital holography: single-shot shape evaluation using speckle displacements and regularization.

Bergström P, Khodadad D, Hällstig E, Sjödahl M.

Appl Opt. 2014 Jan 1;53(1):123-31. doi: 10.1364/AO.53.000123.

PMID:
24513998
7.

Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis.

Bergström P, von Otter M, Nilsson S, Nilsson AC, Nilsson M, Andersen PM, Hammarsten O, Zetterberg H.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):130-7. doi: 10.3109/21678421.2013.839708. Epub 2013 Oct 8.

PMID:
24102512
8.

Alpha emitter radium-223 and survival in metastatic prostate cancer.

Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, Bottomley D, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Coleman R, Vogelzang NJ, O'Bryan-Tear CG, Staudacher K, Garcia-Vargas J, Shan M, Bruland ØS, Sartor O; ALSYMPCA Investigators.

N Engl J Med. 2013 Jul 18;369(3):213-23. doi: 10.1056/NEJMoa1213755.

9.

Variability in prostate and seminal vesicle delineations defined on magnetic resonance images, a multi-observer, -center and -sequence study.

Nyholm T, Jonsson J, Söderström K, Bergström P, Carlberg A, Frykholm G, Behrens CF, Geertsen PF, Trepiakas R, Hanvey S, Sadozye A, Ansari J, McCallum H, Frew J, McMenemin R, Zackrisson B.

Radiat Oncol. 2013 May 24;8:126. doi: 10.1186/1748-717X-8-126.

10.

Assessment of volume segmentation in radiotherapy of adolescents; a treatment planning study by the Swedish Workgroup for Paediatric Radiotherapy.

Kristensen I, Agrup M, Bergström P, Engellau J, Haugen H, Martinsson U, Nilsson K, Taheri-Kadkhoda Z, Lindh J, Nilsson P.

Acta Oncol. 2014 Jan;53(1):126-33. doi: 10.3109/0284186X.2013.782104. Epub 2013 Apr 12.

PMID:
23577745
11.

Measurements and standards for bulk-explosives detection.

Hudson L, Bateman F, Bergstrom P, Cerra F, Glover J, Minniti R, Seltzer S, Tosh R.

Appl Radiat Isot. 2012 Jul;70(7):1037-41. doi: 10.1016/j.apradiso.2011.11.029. Epub 2011 Nov 23.

PMID:
22136814
12.

Relative effects of posture and activity on human height estimation from surveillance footage.

Ramstrand N, Ramstrand S, Brolund P, Norell K, Bergström P.

Forensic Sci Int. 2011 Oct 10;212(1-3):27-31. doi: 10.1016/j.forsciint.2011.05.002. Epub 2011 May 28.

PMID:
21620595
13.

Repeated transient sulforaphane stimulation in astrocytes leads to prolonged Nrf2-mediated gene expression and protection from superoxide-induced damage.

Bergström P, Andersson HC, Gao Y, Karlsson JO, Nodin C, Anderson MF, Nilsson M, Hammarsten O.

Neuropharmacology. 2011 Feb-Mar;60(2-3):343-53. doi: 10.1016/j.neuropharm.2010.09.023. Epub 2010 Oct 1.

PMID:
20888844
14.

Propionibacterium acnes infection induces upregulation of inflammatory genes and cytokine secretion in prostate epithelial cells.

Drott JB, Alexeyev O, Bergström P, Elgh F, Olsson J.

BMC Microbiol. 2010 Apr 26;10:126. doi: 10.1186/1471-2180-10-126.

15.

Metabolomic patterns in glioblastoma and changes during radiotherapy: a clinical microdialysis study.

Wibom C, Surowiec I, Mörén L, Bergström P, Johansson M, Antti H, Bergenheim AT.

J Proteome Res. 2010 Jun 4;9(6):2909-19. doi: 10.1021/pr901088r.

PMID:
20302353
16.

Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.

von Otter M, Landgren S, Nilsson S, Celojevic D, Bergström P, Håkansson A, Nissbrandt H, Drozdzik M, Bialecka M, Kurzawski M, Blennow K, Nilsson M, Hammarsten O, Zetterberg H.

BMC Med Genet. 2010 Mar 2;11:36. doi: 10.1186/1471-2350-11-36.

17.

Anti-leishmanial activity of betulin derivatives.

Alakurtti S, Bergström P, Sacerdoti-Sierra N, Jaffe CL, Yli-Kauhaluoma J.

J Antibiot (Tokyo). 2010 Mar;63(3):123-6. doi: 10.1038/ja.2010.2. Epub 2010 Feb 5.

PMID:
20139867
18.

Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.

von Otter M, Landgren S, Nilsson S, Zetterberg M, Celojevic D, Bergström P, Minthon L, Bogdanovic N, Andreasen N, Gustafson DR, Skoog I, Wallin A, Tasa G, Blennow K, Nilsson M, Hammarsten O, Zetterberg H.

Mech Ageing Dev. 2010 Feb;131(2):105-10. doi: 10.1016/j.mad.2009.12.007. Epub 2010 Jan 12.

PMID:
20064547
19.

Radiation schedules in relation to obliteration and complications in hypofractionated conformal stereotactic radiotherapy of arteriovenous malformations.

Lindvall P, Bergström P, Blomquist M, Bergenheim AT.

Stereotact Funct Neurosurg. 2010;88(1):24-8. doi: 10.1159/000260076. Epub 2009 Nov 20.

PMID:
19940546
20.

Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma.

Reardon DA, Dresemann G, Taillibert S, Campone M, van den Bent M, Clement P, Blomquist E, Gordower L, Schultz H, Raizer J, Hau P, Easaw J, Gil M, Tonn J, Gijtenbeek A, Schlegel U, Bergstrom P, Green S, Weir A, Nikolova Z.

Br J Cancer. 2009 Dec 15;101(12):1995-2004. doi: 10.1038/sj.bjc.6605411. Epub 2009 Nov 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk